BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 23512370)

  • 1. [Do we need even more new biomarkers?].
    Schnabel RB; Blankenberg S
    Dtsch Med Wochenschr; 2013 Mar; 138(13):662-4. PubMed ID: 23512370
    [No Abstract]   [Full Text] [Related]  

  • 2. [Safe diagnosis in acute phase with T-proBNP. Heart failure and acute coronary syndrome can be identified very early].
    Javadzadeh J; Collén AC; Manhem K; Swedberg K
    Lakartidningen; 2008 Feb 27-Mar 4; 105(9):616-9. PubMed ID: 18376704
    [No Abstract]   [Full Text] [Related]  

  • 3. B-type natriuretic peptide in the early diagnosis and risk stratification of acute chest pain.
    Haaf P; Reichlin T; Corson N; Twerenbold R; Reiter M; Steuer S; Bassetti S; Winkler K; Stelzig C; Heinisch C; Drexler B; Freidank H; Mueller C
    Am J Med; 2011 May; 124(5):444-52. PubMed ID: 21531234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natriuretic peptides in acute chest pain and acute coronary syndrome: from pathophysiology to clinical and prognostic applications.
    Aspromonte N; Di Fusco SA; Latini R; Cruz DN; Masson S; Tubaro M; Palazzuoli A
    Coron Artery Dis; 2013 Jan; 24(1):33-9. PubMed ID: 23164752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Japanese-Western consensus meeting on biomarkers.
    Maisel AS; Nakao K; Ponikowski P; Peacock WF; Yoshimura M; Suzuki T; Tsutamoto T; Filippatos GS; Saito Y; Seino Y; Minamino N; Hirata Y; Mukoyama M; Nishikimi T; Nagai R
    Int Heart J; 2011; 52(5):253-65. PubMed ID: 22008432
    [No Abstract]   [Full Text] [Related]  

  • 6. Point-of-care testing for cardiac markers in acute coronary syndromes and heart failure.
    Lewandrowski K
    Clin Lab Med; 2009 Sep; 29(3):561-71. PubMed ID: 19840688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid rule out of myocardial infarction with the use of copeptin as a biomarker for cardiac injury.
    Jayasinghe R; Narasimhan S; Tran TH; Paskaranandavadivel A
    Intern Med J; 2014 Sep; 44(9):921-4. PubMed ID: 25201424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Third universal definition of myocardial infarction: update, caveats, differential diagnoses.
    Tehrani DM; Seto AH
    Cleve Clin J Med; 2013 Dec; 80(12):777-86. PubMed ID: 24307162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Natriuretic peptides--new diagnostic markers in heart disease].
    Angermann CE; Ertl G
    Herz; 2004 Sep; 29(6):609-17. PubMed ID: 15912436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Viewpoint: management of the patient with an 'incidentally' raised troponin.
    Ho J
    Acute Med; 2011; 10(3):123-5. PubMed ID: 21904704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A non-coronary syndrome cause of elevated troponin.
    Howell DS; Perret JN; Mandry C
    J La State Med Soc; 2011; 163(4):215-7. PubMed ID: 21954655
    [No Abstract]   [Full Text] [Related]  

  • 12. [Cardiac troponin].
    Mingels AM; Gorgels TP; van Dieijen-Visser MP
    Ned Tijdschr Geneeskd; 2012; 156(42):A5044. PubMed ID: 23075777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biomarkers in clinical practice.
    Alpert JS
    Am J Med; 2011 Aug; 124(8):677-8. PubMed ID: 21683327
    [No Abstract]   [Full Text] [Related]  

  • 14. [Biomarkers in the diagnosis of cardiovascular emergencies : Acute coronary syndrome and differential diagnoses].
    Möckel M
    Internist (Berl); 2019 Jun; 60(6):564-570. PubMed ID: 31062038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Redefinition of myocardial infarction--relevance of biomarkers].
    Weber M; Hamm C
    Herz; 2008 Mar; 33(2):115-21. PubMed ID: 18344030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Building a better mousetrap for chest pain.
    Baumann BM; Miller CD
    Acad Emerg Med; 2012 May; 19(5):594-7. PubMed ID: 22594365
    [No Abstract]   [Full Text] [Related]  

  • 17. Biomarkers in acute coronary syndrome and percutaneous coronary intervention.
    Searle J; Danne O; Müller C; Mockel M
    Minerva Cardioangiol; 2011 Jun; 59(3):203-23. PubMed ID: 21516070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct comparison of the diagnostic value of point-of-care tests detecting heart-type fatty acid binding protein or glycogen phosphorylase isoenzyme BB in patients with acute coronary syndromes with persistent ST-segment elevation.
    Figiel Ł; Wraga M; Bednarkiewicz Z; Lipiec P; Smigielski J; Krzemińska-Pakuła M; Kasprzak JD
    Kardiol Pol; 2011; 69(1):1-6. PubMed ID: 21267954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heart-type fatty acid-binding protein: an overlooked cardiac biomarker.
    Goel H; Melot J; Krinock MD; Kumar A; Nadar SK; Lip GYH
    Ann Med; 2020 Dec; 52(8):444-461. PubMed ID: 32697102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic information of glycogen phosphorylase isoenzyme BB in patients with suspected acute coronary syndrome.
    Lillpopp L; Tzikas S; Ojeda F; Zeller T; Baldus S; Bickel C; Sinning CR; Wild PS; Genth-Zotz S; Warnholtz A; Lackner KJ; Münzel T; Blankenberg S; Keller T
    Am J Cardiol; 2012 Nov; 110(9):1225-30. PubMed ID: 22818785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.